Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 3,410.00
+110.00 (3.33%)
Jul 18, 2025, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 37.30 billion as of July 18, 2025.
Market Cap
37.30B
Enterprise Value
37.14B
Revenue
1.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,410.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 37.30B, a decrease of -58.65%. That is a compound annual growth rate of -58.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 37.30B | -15.96% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.16T |
| Celltrion | 39.84T |
| ALTEOGEN | 26.11T |
| Yuhan | 10.15T |
| SK Biopharmaceuticals | 8,074.10B |
| HLB Co., Ltd. | 7,083.28B |
| Peptron | 6,604.80B |
| PharmaResearch | 6,005.22B |